Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ImmuneOncia and 3D Medicines Signed Exclusive License Agreement to Develop, Manufacture and Commercialize IMC-002 in Greater China 2021-03-31 09:00
Innovent Announces Parsaclisib (IBI376) was Granted Breakthrough Therapy Designation by the NMPA for the Treatment of Relapsed/Refractory Follicular Lymphoma 2021-03-31 08:00
Viva Biotech Announced 2020 Annual Results 2021-03-31 07:03
binx health Receives FDA CLIA Waiver for Chlamydia and Gonorrhea Test, Expanding Critical Access to Single-Visit Diagnoses 2021-03-31 06:11
European Commission Approves mAbxience's Bevacizumab For The Treatment Of Certain Types Of Cancer 2021-03-31 05:30
Ajinomoto Bio-Pharma Services Expands Manufacturing Agreement with AstraZeneca to Include Drug Product Manufacturing 2021-03-31 01:04
WuXi AppTec Reports Strong 2020 Annual Results 2021-03-30 21:10
Innovent Announced Financial Results for Full Year Ended December 31, 2020 and Corporate Progress 2021-03-30 20:52
VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary Subsidiary 2021-03-30 20:30
Fosun International Announces 2020 Annual Results: Total Revenue Amounted to RMB136.6 Billion, Gathering Strength to Fuel Growth 2021-03-30 20:03
AffaMed Therapeutics Announces Completion of over US$170 Million Series B Financing Led by Lake Bleu Capital to Further Development of Ophthalmic and Neuroscience Pipeline 2021-03-30 19:30
GemVax's highly promising Phase II Alzheimer's disease clinical trial results targeting telomerase published in prestigious Alzheimer's Research & Therapy' journal 2021-03-30 19:21
Instylla Announces Enrollment of Initial Patients in the Embrace™ Hydrogel Embolic System Global Randomized Multi-Center Clinical Trial 2021-03-30 19:02
Frost & Sullivan Reveals How Virtual Care will Impact the Trillion-dollar Global Healthcare Market 2021-03-30 18:02
HI-NANO: Hisense's new technology inactivates COVID-19 with a rate up to 93.54% 2021-03-30 16:25
Ascletis Announces Investment Escalation in R&D of Cancer Lipid Metabolism and Oral Checkpoint Inhibitors 2021-03-30 08:00
TurtleTree Scientific and JSBiosciences enter into a strategic partnership for the development of cell culture media and contract manufacturing services 2021-03-30 06:00
Novel Phenomics NASH In Vitro Assay Presented by InSphero AG and PharmaNest Inc at 2021 Society of Toxicology Meeting 2021-03-30 05:20
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020 2021-03-30 04:30
VolitionRx Limited Appoints Two New Directors 2021-03-30 04:10
1 637 638 639 640 641 1619